Viewing Study NCT04907968


Ignite Creation Date: 2025-12-24 @ 5:59 PM
Ignite Modification Date: 2025-12-29 @ 4:08 PM
Study NCT ID: NCT04907968
Status: TERMINATED
Last Update Posted: 2023-10-10
First Post: 2021-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer
Sponsor: Mersana Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module